543 related articles for article (PubMed ID: 18348001)
1. Estimated risk for secondary cancer in the contra-lateral breast following radiation therapy of breast cancer.
Johansen S; Danielsen T; Olsen DR
Acta Oncol; 2008; 47(3):391-6. PubMed ID: 18348001
[TBL] [Abstract][Full Text] [Related]
2. A planning comparison of dose patterns in organs at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT and volumetric modulated arc treatment techniques.
Johansen S; Cozzi L; Olsen DR
Acta Oncol; 2009; 48(4):495-503. PubMed ID: 19169915
[TBL] [Abstract][Full Text] [Related]
3. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma.
Hodgson DC; Koh ES; Tran TH; Heydarian M; Tsang R; Pintilie M; Xu T; Huang L; Sachs RK; Brenner DJ
Cancer; 2007 Dec; 110(11):2576-86. PubMed ID: 17941006
[TBL] [Abstract][Full Text] [Related]
4. Calculated risk of breast cancer following mantle irradiation determined by measured dose.
Janjan NA; Zellmer DL
Cancer Detect Prev; 1992; 16(5-6):273-82. PubMed ID: 1473117
[TBL] [Abstract][Full Text] [Related]
5. Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients.
Weber DC; Johanson S; Peguret N; Cozzi L; Olsen DR
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):490-7. PubMed ID: 20800383
[TBL] [Abstract][Full Text] [Related]
6. Dose evaluation and risk estimation for secondary cancer in contralateral breast and a study of correlation between thorax shape and dose to organs at risk following tangentially breast irradiation during deep inspiration breath-hold and free breathing.
Johansen S; Vikström J; Hjelstuen MH; Mjaaland I; Dybvik KI; Olsen DR
Acta Oncol; 2011 May; 50(4):563-8. PubMed ID: 21370938
[TBL] [Abstract][Full Text] [Related]
7. Phenomenological modelling of second cancer incidence for radiation treatment planning.
Pfaffenberger A; Schneider U; Poppe B; Oelfke U
Z Med Phys; 2009; 19(4):236-50. PubMed ID: 19962082
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy.
Tsougos I; Mavroidis P; Rajala J; Theodorou K; Järvenpää R; Pitkänen MA; Holli K; Ojala AT; Lind BK; Hyödynmaa S; Kappas C
Phys Med Biol; 2005 Aug; 50(15):3535-54. PubMed ID: 16030381
[TBL] [Abstract][Full Text] [Related]
9. Effect of radiotherapy volume and dose on secondary cancer risk in stage I testicular seminoma.
Zwahlen DR; Martin JM; Millar JL; Schneider U
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):853-8. PubMed ID: 18164856
[TBL] [Abstract][Full Text] [Related]
10. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
van den Belt-Dusebout AW; Aleman BM; Besseling G; de Bruin ML; Hauptmann M; van 't Veer MB; de Wit R; Ribot JG; Noordijk EM; Kerst JM; Gietema JA; van Leeuwen FE
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1420-9. PubMed ID: 19931732
[TBL] [Abstract][Full Text] [Related]
11. Radiation-induced leukemia at doses relevant to radiation therapy: modeling mechanisms and estimating risks.
Shuryak I; Sachs RK; Hlatky L; Little MP; Hahnfeldt P; Brenner DJ
J Natl Cancer Inst; 2006 Dec; 98(24):1794-806. PubMed ID: 17179481
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer after radiotherapy for skin hemangioma in infancy.
Lundell M; Mattsson A; Hakulinen T; Holm LE
Radiat Res; 1996 Feb; 145(2):225-30. PubMed ID: 8606933
[TBL] [Abstract][Full Text] [Related]
13. Incidence of primary malignancies other than breast cancer among women treated with radiation therapy for benign breast disease.
Mattsson A; Hall P; Rudén BI; Rutqvist LE
Radiat Res; 1997 Aug; 148(2):152-60. PubMed ID: 9254734
[TBL] [Abstract][Full Text] [Related]
14. Quantification of contralateral breast dose and risk estimate of radiation-induced contralateral breast cancer among young women using tangential fields and different modes of breathing.
Zurl B; Stranzl H; Winkler P; Kapp KS
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):500-5. PubMed ID: 22633190
[TBL] [Abstract][Full Text] [Related]
15. The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer.
Schneider U; Lomax A; Besserer J; Pemler P; Lombriser N; Kaser-Hotz B
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):892-7. PubMed ID: 17459608
[TBL] [Abstract][Full Text] [Related]
16. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields.
Nguyen F; Rubino C; Guerin S; Diallo I; Samand A; Hawkins M; Oberlin O; Lefkopoulos D; De Vathaire F
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):908-15. PubMed ID: 18262102
[TBL] [Abstract][Full Text] [Related]
17. Biologically effective dose-response relationship for breast cancer treated by conservative surgery and postoperative radiotherapy.
Plataniotis GA; Dale RG
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):512-7. PubMed ID: 19625139
[TBL] [Abstract][Full Text] [Related]
18. Cancer in the contralateral breast after radiotherapy for breast cancer.
Boice JD; Harvey EB; Blettner M; Stovall M; Flannery JT
N Engl J Med; 1992 Mar; 326(12):781-5. PubMed ID: 1538720
[TBL] [Abstract][Full Text] [Related]
19. Carcinogenic effects of radiotherapy for breast cancer.
Neugut AI; Weinberg MD; Ahsan H; Rescigno J
Oncology (Williston Park); 1999 Sep; 13(9):1245-56; discussion 1257, 1261-5. PubMed ID: 10509322
[TBL] [Abstract][Full Text] [Related]
20. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models.
Rancati T; Wennberg B; Lind P; Svane G; Gagliardi G
Radiother Oncol; 2007 Mar; 82(3):308-16. PubMed ID: 17224197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
